Skip to main content

Tweets

Dr Blazer sheds light on the multilayered SDOHs as they affect outcomes in chronic diseases. Head over to #ACR21 https://t.co/Jq7aiRV3MD
Chinny Jumai Osuorji,MD @MediaRheum ( View Tweet )
4 years 8 months ago
Factors associated with Anti Drug Ab against TNFi over 2-y in axSpA pts are: ⭐️ 🔼 Disease activity ⭐️Development of adverse events ⭐️Treatment discontinuation Abst #0936 #ACR21 @RheumNow

swethaann23 @swethaann23 ( View Tweet )

4 years 8 months ago
Clinical Pearl at #ACR21 from Dr. John Stone: ⭐️Listen for bruits on patient's back, specifically, on both sides of the spine. ➡️If you hear a bruit, the Takayasu's lesion may be coming from either: *️⃣Pulmonary artery *️⃣Descending Aorta #ACRBest @RheumNow https://t.co/gVpeh7iowk
Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )
4 years 8 months ago
Just to fast-forward slightly, baseline CV risk was equal, since you asked... #ACR21 https://t.co/W3SLbFbQVE
David Liew @drdavidliew ( View Tweet )
4 years 8 months ago
This is the overall MACE data. Those overall HR certainly in the wrong direction, even if they don't cross 1. #ACR21 https://t.co/5RGT3QMdti
David Liew @drdavidliew ( View Tweet )
4 years 8 months ago
Pearl: Most oral lesions in #lupus are painless. The classic oral lesion is a lacy, reticular pattern superimposed on an erythematous plaque. @RheumNow #ACR21 https://t.co/nxWnppxsZI
4 years 8 months ago
John Stone: "If I'd had time I would have said more" Fantastic #SecretsAndPearls session! 👏 Huge breadth and depth of topics covered- if only there was more time! #ACR21 @RheumNow https://t.co/oFyj8enMMk
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 8 months ago
ORAL surveillance TOFA vs. TNFi: in patients with > 50yo > 1 CV risk MTX IR -# ⬆️ in MACE and MI (not stroke) -MACE risk factors on TOFA smoking, >65 male gender -# ⬆️ MACE in its w/ any of these RF What are you going to tell your patients? #Abtr0958 #ACR21 #ACRBest @RheumNow https://t.co/81kVTH63bb
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 8 months ago
Clinical Pearl at #ACR21 from Dr. J. Stone: ⭐️Ferritin:ESR ratio helps distinguishes systemic JIA flares from macrophage activation syndrome (MAS). ⭐️During MAS: *️⃣Ferritin rapidly rises as an acute phase reactant *️⃣ESR declines as fibrinogen is consumed. #ACRBest @RheumNow

Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )

4 years 8 months ago
✨Great Pearls when screening patients for clinically suspect #Scleroderma or #Juvenile #Dermatomyositis 📌 Don’t Stop Work Up at Negative ANA if strongly suspect SSc 📌 #Myositis Specific Antibodies have different phenotypes in kids than adults (MDA-5, TIF-1g, NXP-2) #ACR21 https://t.co/KrkkzA5bkV
Ashima Makol MD @AshimaMakol ( View Tweet )
4 years 8 months ago
Clinical (Peds Rheum) Pearl at #ACR21 by Dr. John Stone: ⭐️Dilated capillaries at the eyelid margin is the last cutaneous sign to resolve in inflammatory myositis! ⭐️Do not stop treatment until this sign is gone! #ACRBest @RheumNow https://t.co/5H3Q9mTN9x
Meral K. El Ramahi, MD @MeralElRamahiMD ( View Tweet )
4 years 8 months ago
HZV in pts w/ #rheumatic dse by Dr CCMok et al 🔸Prevalence rates of HZV infxn (per 100py): SLE 1.7, RA 0.64, other RDs 0.76 🔸RFs assoc'd w/1st HZV infection 📌#SLE dx, serum albumin, serum creatinine; ⬆lympho/neutro ratio, CYC & Prednisolone use @RheumNow #ACR21 abs0862 https://t.co/TXRmoBBDXK
4 years 8 months ago
×